First Trust Nasdaq Pharmaceuticals ETF
FTXHDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 30, 2026 | $0.09 | 2026-06-25 | 2026-06-25 |
| March 31, 2026 | $0.06 | 2026-03-26 | 2026-03-26 |
| December 31, 2025 | $0.13 | 2025-12-12 | 2025-12-12 |
| September 30, 2025 | $0.15 | 2025-09-25 | 2025-09-25 |
| June 30, 2025 | $0.09 | 2025-06-26 | 2025-06-26 |
Dividends Summary
- Consistent Payer: First Trust Nasdaq Pharmaceuticals ETF has rewarded shareholders with 40 dividend payments over the past 10 years.
- Total Returned Value: Investors who held FTXH shares during this period received a total of $3.10 per share in dividend income.
- Latest Payout: The most recent dividend of $0.09/share was paid 18 days ago, on June 30, 2026.
- Yield & Schedule: FTXH currently pays dividends quarterly with an annual yield of 1.10%.
- Dividend Growth: Since 2016, the dividend payout has grown by 1542.9%, from $0.01 to $0.09.
Company News
Bristol-Myers Squibb (BMY) stock declined 2.55% to $57.63 on Wednesday ahead of Thursday's quarterly earnings report. The company expanded its manufacturing partnership with Oxford Biomedica (OXB) through a new Commercial Supply Agreement for lentiviral vector manufacturing for CAR-T therapies, with production beginning in 2026 at facilities in O...
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
